Beyond the Breaking News

Researchers identify new gene mutation that alters Alzheimer's disease risk

United States News News

Researchers identify new gene mutation that alters Alzheimer's disease risk
United States Latest News,United States Headlines

A groundbreaking study has shed new light on the genetic underpinnings of Alzheimer's disease.

A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease. The team's research, rooted in human genetics studies, has unearthed a critical mutation within a key gene operating in the brain's immune cells, potentially elevating the risk of Alzheimer's disease.

The research team included several IU investigators within Stark Neurosciences Research Institute -- Gary Landreth, PhD, the Martin Professor of Alzheimer's Research; Bruce Lamb, PhD, executive director of Stark Neuroscience Research Institute; Stephanie Bissel, PhD, assistant professor of genetics; Kwangsik Nho, PhD, associate professor of radiology and imaging sciences; and Adrian Oblak, PhD, assistant professor of radiology and imaging sciences. Their research was recently published in the journalAndy Tsai, PhD, a graduate of the Medical Neurosciences Graduate Program, was the driving force behind the research, encompassing his PhD thesis. Tsai, now a postdoctoral fellow at Stanford University Medical School, has significantly contributed to unraveling the mysteries of Alzheimer's disease. The focal point of the investigation revolved around the phospholipase C gamma 2 gene, intricately entwined within microglia -- central to the brain's immune response. This genetic anomaly, discovered through analysis of the gene's biological workings, showcased the impact of specific rare variants. The study found that the M28L variant heightened the susceptibility to Alzheimer's disease, whereas the P522R variant exhibited a risk-reducing effect. Innovative mouse models of Alzheimer's disease developed by the NIH-funded MODEL-AD Center allowed researchers to substantiate their findings. Immune cells harboring risk-reducing gene variants demonstrated a reduction in amyloid plaques, while those carrying the risk-elevating variants exhibited a surge in plaque accumulation. The study unveiled specific gene clusters orchestrating these alterations in immune cell behavior within microglia. Microglia, often regarded as the brain's first line of defense against infections, toxins and damage, has garnered attention for its significant role in influencing disease susceptibility. "The microglial response affects neurons which then affects the capacity to learn and form new memories," Landreth said. Extensive collaboration within Stark Neurosciences Research Institute enabled a comprehensive evaluation of the gene's implications. This included a comparison between preclinical data from animal models and real-world human data on Alzheimer's disease. "This represents a collaboration that could've only been achieved at Stark," Landreth said."We used human genetics to investigate and identify a mechanism, and indeed we have." The study's paramount importance lies in explaining the critical role of microglial immune responses and their potential to impact disease risk, positively or negatively. This discovery promises to reshape the understanding of Alzheimer's disease and carve a path toward targeted therapeutics, which is being pursued by the NIH-funded TREAT-AD Center.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceDaily /  🏆 452. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

An Existing Drug for Multiple Sclerosis Might Be Useful for Alzheimer's Too, Study FindsAn Existing Drug for Multiple Sclerosis Might Be Useful for Alzheimer's Too, Study FindsScientists have found evidence in mice and human brain tissue that the drug ponesimod can reduce inflammation and toxic amyloid plaques common in Alzheimer's.
Read more »

Bone marrow in the skull could be used to monitor Alzheimer’s, MS and moreBone marrow in the skull could be used to monitor Alzheimer’s, MS and moreNew observations of skull cell signals and skull tunnels suggest bone marrow there could be used to monitor neurological diseases.
Read more »

The Alzheimer’s Association Brain Bus is coming to JacksonvilleThe Alzheimer’s Association Brain Bus is coming to JacksonvilleThe Alzheimer's Association Brain Bus will make several stops in Jacksonville September 6 to 8, offering free support services to those facing the disease, including hurricane preparedness guidance for dementia caregivers. More than 17,000 Duval County residents age 65 and up are estimated to be living with Alzheimer's.
Read more »

Bob Barker Had Alzheimer’s DiseaseBob Barker Had Alzheimer’s DiseaseLongtime Price Is Right host Bob Barker had been quietly suffering from Alzheimer’s disease at the time of his death, TMZ reports according to the legendary TV host’s death certificate,…
Read more »

Bob Barker died from complications of Alzheimer'sBob Barker died from complications of Alzheimer'sAccording to the legendary game show host's death certificate, Bob Barker died from complications of Alzheimer's as well as hypertension and hyperthyroidism.
Read more »

Researchers to study Alzheimer's disease in marmosetsResearchers to study Alzheimer's disease in marmosetsNeuroscientists created the first non-human primate model of hereditary Alzheimer's in marmosets to accelerate the pace of drug discovery and rebuild the foundation for future translational studies.
Read more »



Render Time: 2026-06-11 03:42:56